HHLR ADVISORS, LTD. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
HHLR ADVISORS, LTD. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3,921,400
-54.6%
623,434
-22.1%
0.08%
-63.4%
Q3 2022$8,640,000
-5.3%
800,0000.0%0.23%
+16.4%
Q2 2022$9,120,000
+25.1%
800,0000.0%0.20%
+28.3%
Q1 2022$7,288,000
-38.9%
800,0000.0%0.15%
-17.4%
Q4 2021$11,936,000
-41.9%
800,0000.0%0.18%
-31.6%
Q3 2021$20,560,000
-1.5%
800,0000.0%0.27%
+25.1%
Q2 2021$20,864,000
-26.1%
800,0000.0%0.22%
-22.9%
Q1 2021$28,240,000
+39.9%
800,0000.0%0.28%
+73.3%
Q4 2020$20,192,000
-33.1%
800,0000.0%0.16%
-29.7%
Q3 2020$30,168,000
-11.9%
800,0000.0%0.23%
-26.8%
Q2 2020$34,256,000800,0000.31%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders